Argatroban contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Argatroban}} {{CMG}}; {{AE}} {{JH}} ==TITLE== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXO..." |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{JH}} | {{CMG}}; {{AE}} {{JH}} | ||
== | ==Contraindications== | ||
Argatroban Injection is supplied in a single use vial containing 50 mg argatroban in 50 mL aqueous solution (1 mg/mL). The solution is ready for intravenous infusion. <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher = | date = | accessdate = }}</ref> | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher = | date = | accessdate = }}</ref> | |||
==Reference== | ==Reference== |
Revision as of 01:55, 4 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]
Contraindications
Argatroban Injection is supplied in a single use vial containing 50 mg argatroban in 50 mL aqueous solution (1 mg/mL). The solution is ready for intravenous infusion. [1]
Reference
Adapted from the FDA Package Insert.